Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000035

CEO bought 490,500 shares at an average $0.01 ($5,180)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

25 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-28 Purchase : show line 1 in the form +30,000 $0.01 $300 23,505,597 D
2019-05-28 Purchase : show line 2 in the form +20,000 $0.01 $200 23,525,597 D
2019-05-28 Purchase : show line 3 in the form +50,000 $0.01 $500 23,575,597 D
2019-05-28 Purchase : show line 4 in the form +50,000 $0.01 $525 23,625,597 D
2019-05-28 Purchase : show line 5 in the form +25,500 $0.01 $268 23,651,097 D
2019-05-28 Purchase : show line 6 in the form +10,000 $0.01 $104 23,661,097 D
2019-05-28 Purchase : show line 7 in the form +20,000 $0.01 $210 23,681,097 D
2019-05-28 Purchase : show line 8 in the form +50,000 $0.01 $575 23,731,097 D
Open-market purchases · 490,500 sh · avg $0.01 · $5,180
Loading xslF345X03/primary_doc.xml…